Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study

• المؤلفون الرئيسيون: Laura Fanning, Ian C.K. Wong, Xue Li, Esther W. Chan, Pajaree Mongkhon, Kenneth K.C. Man, Li Wei, Wai K. Leung, Peteris Darzins, Simon Bell, Jenni Ilomaki, Wallis C.Y. Lau
• التنسيق: دورية
• منشور في: 2020
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090958669&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/70971

© 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. Purpose: Comparative gastrointestinal bleeding (GIB) risk between rivaroxaban and low-dose aspirin is unknown in patients with atrial fibrillation (AF). This study investigated GIB risk with rivaroxaba...